Literature DB >> 7853570

Renal cell carcinoma: tumor size, stage and survival. Members of the Cancer Incidence and End Results Committee.

P D Guinan1, N J Vogelzang, A M Fremgen, J S Chmiel, J L Sylvester, S F Sener, J P Imperato.   

Abstract

In an attempt to define the relationship among tumor size, stage and survival, the Cancer Incidence and End Results Committee of the American Cancer Society, Illinois Division, Inc. reviewed the records of 2,473 patients with a histological diagnosis of renal cell carcinoma. Tumor size was related to stage and survival. Larger tumors were generally associated with an increased stage (p < or = 0.0005) as well as poorer survival (p < or = 0.005). For Robson stages II, III and IV, tumor size may contribute additional prognostic information for patient survival.

Entities:  

Mesh:

Year:  1995        PMID: 7853570

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses.

Authors:  Catherine Roy; Benoit Sauer; Véronique Lindner; Hervé Lang; Christian Saussine; Didier Jacqmin
Journal:  Eur Radiol       Date:  2006-06-07       Impact factor: 5.315

2.  Expression of the interleukin 6 receptor in primary renal cell carcinoma.

Authors:  V Costes; J Liautard; M C Picot; M Robert; N Lequeux; J Brochier; P Baldet; J F Rossi
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

3.  Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

Authors:  J W Slaton; K Inoue; P Perrotte; A K El-Naggar; D A Swanson; I J Fidler; C P Dinney
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

4.  Clinical and prognostic factors for renal parenchymal, pelvis, and ureter cancers in SEER registries: collaborative stage data collection system, version 2.

Authors:  Sean F Altekruse; Lois Dickie; Xiao-Cheng Wu; Mei-Chin Hsieh; Manxia Wu; Richard Lee; Scott Delacroix
Journal:  Cancer       Date:  2014-12-01       Impact factor: 6.860

Review 5.  Treatment of metastatic renal cell carcinoma and renal pelvic cancer.

Authors:  Nozomu Tanji; Masayoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2011-04-12       Impact factor: 2.801

6.  Significance of angiogenesis and microvascular invasion in renal cell carcinoma.

Authors:  Yoram Dekel; Rumelia Koren; Valentina Kugel; Pinhas M Livne; Rivka Gal
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

Review 7.  Radiofrequency ablation of renal tumors.

Authors:  Andreas H Mahnken; Rolf W Günther; Josef Tacke
Journal:  Eur Radiol       Date:  2004-05-19       Impact factor: 5.315

8.  Changing concepts in the surgery of renal cell carcinoma.

Authors:  Axel S Merseburger; Markus A Kuczyk
Journal:  World J Urol       Date:  2008-02-12       Impact factor: 4.226

Review 9.  Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillance.

Authors:  David Y T Chen; Robert G Uzzo
Journal:  J Natl Compr Canc Netw       Date:  2009-06       Impact factor: 11.908

Review 10.  Novel concepts in the staging of renal cell carcinoma.

Authors:  Dan Leibovici; Arie Lindner; Avishay Sella; Amnon Zisman
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.